Tranexamic acid to reduce bleeding in sleeve gastrectomy and mini gastric bypass
Official title: Role of Tranexamic Acid in Reducing Hemorrhagic Events in Bariatric Surgery
Run by Patel Hospital, Pakistan · NCT07098780 · Data updated 2026-11-12
This trial will test whether giving tranexamic acid before laparoscopic sleeve gastrectomy or mini gastric bypass reduces bleeding in adults with morbid obesity.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Patel Hospital, Pakistan Academic / other |
| Locations | 1 site (Karachi, Sindh) |
| Status | Recruiting |
| Started | June 12, 2023 |
| Main results expected | July 31, 2025 |
| Study ends | August 31, 2025 |
| Registry record updated | August 1, 2025 |
| Trial ID | NCT07098780 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18 years and older) with morbid obesity scheduled for laparoscopic sleeve gastrectomy or mini gastric bypass who are not taking anticoagulant or antiplatelet medications and have no bleeding disorder are ideal candidates.
✕Probably not a fit
Patients on antiplatelet or anticoagulant therapy, those with inherited or acquired bleeding disorders, or those with a known allergy to tranexamic acid would be excluded and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, placebo-controlled Phase 4 trial comparing tranexamic acid given before surgery versus placebo in adults undergoing laparoscopic sleeve gastrectomy (LSG) or mini gastric bypass (MGB). Participants are randomized to receive either tranexamic acid or normal saline before their operation and then undergo standard perioperative care. Investigators will measure intraoperative blood loss, postoperative hemoglobin levels, and monitor for bleeding-related complications and other adverse events. The trial is conducted at a single site (Patel Hospital, Karachi) and excludes patients on anticoagulants, with bleeding disorders, or with known TXA allergy.
Why it matters
Potential benefit: If successful, tranexamic acid could reduce intraoperative and postoperative bleeding, lower transfusion needs, and decrease bleeding-related complications in bariatric surgery patients.
How similar studies have gone: Tranexamic acid has reduced surgical bleeding in many other specialties and some smaller bariatric studies suggest benefit, but large randomized evidence specifically in bariatric procedures is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients above 18 years of age AND * Undergoing Laparoscopic Sleeve Gastrectomy and MGB * Morbid obesity Exclusion Criteria: * Patients on anti-platelets/anti-coagulants * Patients with inherited or acquired bleeding disorders * Patients with any acute medical condition predisposing to bleeding * Hormonal contraceptives * Known Allery to TXA * Female hormonal replacement therapy
Where it's running
-
Patel Hospital
Karachi, Sindh, Pakistan Recruiting
Study contacts
- Study coordinator: Yusra Jamshed, MBBS
- Email: yusra.j.khan@gmail.com
- Phone: +923343914332
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Postoperative nausea, vomiting and pain after bariatric surgery in Sweden
This study looks at how often people have nausea, vomiting, and pain after bariatric surgery in Sweden and whether anesthesia type or regional blocks affect those outcomes.
-
Predicting Quality of Life After Bariatric Surgery from Pre-Surgery Profiles
This study tests whether pre-surgical patient traits can predict how quality of life changes after bariatric surgery for adults in the GEROM73 program.
-
Gum bacteria in people having bariatric surgery with BMI greater than 30
This will see if people with obesity (BMI ≥30) having bariatric surgery have different gum bacteria depending on whether their BMI is 30–35 or above 35.
-
Impact of Bariatric Surgery on Bone Health in Type 2 Diabetes Patients
This study is testing how sleeve gastrectomy surgery affects bone health in people with type 2 diabetes compared to those who are overweight but don’t have diabetes.
-
15-year outcomes after sleeve gastrectomy in France
This study looks at how people who had sleeve gastrectomy have fared over 15 years to see long-term weight changes and health effects.
-
Mother and baby health after bariatric surgery in pregnancy
This study follows pregnant women who have had bariatric surgery and those who have not to see how nutrition, pregnancy health, and baby outcomes compare.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.